Document is current
Any future updates will be listed below
-
Authors
Cohen, Camille
Le Goff, Océane
Soysouvanh, Frédéric
Vasseur, Florence
Tanou, Marine
Nguyen, Clément
Amrouche, Lucile
Le Guen, Julien
Saltel‐Fulero, Oriana
Meunier, Tanguy
Nguyen‐Khoa, Thao https://orcid.org/0000-0003-3738-7299
Rabant, Marion
Nochy, Dominique
Legendre, Christophe
Friedlander, Gérard
Childs, Bennett G
Baker, Daren J https://orcid.org/0000-0001-9006-1939
Knebelmann, Bertrand
Anglicheau, Dany
Milliat, Fabien https://orcid.org/0000-0001-8249-9498
Terzi, Fabiola https://orcid.org/0000-0001-6107-8125
-
Funding
Funding for this research was provided by:
Institut National de la Santé et de la Recherche Médicale
Universite de Paris
Assistance Publique ‐ Hôpitaux de Paris
Agence Nationale Recherche
- License Information
-
More Information
Article History
Received: 19 February 2021
Revised: 16 September 2021
Accepted: 22 September 2021
First Online: 2 November 2021
Conflict of interest
: B.G.C. and D.J.B. are shareholders and coinventors on patent applications licensed to or filed by Unity Biotechnology, a company developing senolytic medicines, including small molecules that selectively eliminate senescent cells. Research in the Baker laboratory has been reviewed by the Mayo Clinic Conflict of Interest Review Board and is being conducted in compliance with Mayo Clinic conflict of interest policies. All other authors declare that they have no conflict of interest.
